I think it would be smart to prepare for both an increase in #COVID19 due to seasonal (behavioural) change & a new variant.
As so many others have elegantly illustrated, new lineages of SC2 are sparking interest.
Since the dominance of BA.5 (22B), most of the world hasn't seen much else move in (though in some places BA.4/22A hangs on), with the exception of India & BA.2.75 (22D).
However, in the background #SARSCoV2 hasn't stopped changing, & recently a spate of new variants have been identified that seem to have converged on similar sets of mutations.
Why does this matter?
Mutations themselves are random, but what ends up sticking around isn't - things that give a fitness advantage.
When see something appear multiple times in a short period, it can be a sign that this is something that's working well for the virus now.
6/17
The two variants under most discussion at the moment are BQ.1.1 (comes from BA.5/22B) & BA.2.75.2 (comes from 22D). @PeacockFlu & @EricTopol give nice illustrative overviews:
We've learned in the past that predicting impact from a list of mutations alone isn't completely straightforward. However, the mutations we see in BQ.1.1 & BA.2.75.2 (& others, as noted above) are in locations that could impact immune evasion & receptor binding.
8/17
Currently, we expect that selection pressure on the virus is largely to get around immunity, with so much of the world having a level of protection due to vaccination, infection, or both. This is a long-term game for many endemic viruses. So it's not surprising, but...
9/17
The big questions are ⏲️ When? and ⚖️ How much?
⏲️ WHEN might a new variant start to sweep through & dominate?
⚖️ HOW MUCH will it matter in terms of cases & clinical severity?
And these aren't easy questions to answer at the moment.
10/17
So, question 3 - 🤷🏻♀️ What should we do?
Given the time of year and what we are seeing in mutations & growth, I think we may well face a double-impact of autumn & a new variant in the next couple of months. We should prepare for this, & hope we don't need those preparations
11/17
We don't know & can't currently predict 'how bad' such a wave might be.
But, even if it's fairly 'not bad', we saw a notable impact of BA.5 (which was 'not bad') this summer due to absences 🤒, particularly in hospitals & airlines 🏥🛫.
12/17
While hospitalizations & deaths are obviously the most critical of outcomes, we do seem to be stuck in a bit of a black-&-white that if these are low, everything else is fine 🙈
I think we need to change that. Huge workplace absences can really impact our society.
13/17
So, 🤷🏻♀️ WHAT should we do?
- Start & encourage booster roll-out💉
- Decide our 'thresholds of action'📈
- Make a plan for how to react🗒️
- Publicise so people are prepared📢
No govt is keen to encourage masks or homeoffice again, I know!
But in my opinion, it's better to have these on the table to prevent disruptions to schools, transport, infrastructure & deliveries, if cases & absences start to threaten those this autumn/winter.
15/17
In a personal way, you can help too:
When cases rise and/or you're in a crowded, ill-ventilated place, wear a mask! 😷
If you're sick (with anything at all!) stay home if at all possible. Even if not COVID, nobody wants your cold! 🙅🏻♀️🤧 (And those cause absences too!)
16/17
We've got a lot of experience (& immunity!) under our belt now - we'll never be back to those first pandemic times. But at the same time, it's smart to stay alert & prepared. This winter will be tough in many ways - let's do what we can to stop #COVID making it tougher! ✊🏻
17/17
• • •
Missing some Tweet in this thread? You can try to
force a refresh
📡CoVariants.org Update📡
This update doesn't impact the visualizations or the data, but @MoiraZuber deserves a public appreciation thread thanks to her tireless efforts & recent refactoring achievements - so here it is!
1/7
CoVariants is a labour of love - I'm always trying to squeeze it in between the million other things I 'should' be doing (which hopefully lead to publications, the hard currency of academia). Because of this, the time I can put into CoVariants is sadly limited 😞⌛️
2/7
Thus, CoVariants code is all a little bit hacked together in spare minutes. As a result, the main processing script had grown arms, legs, toes & tentacles - it took >2.5 hours to run!! 🧌⏱️
Obviously, very sub-par for development!
3/7
Note that for the moment I don't have anything but year for these sequences, so month is being inferred by the pipeline - note the wide confidence interval on the date!
However, zooming into the VP1 build, we can see some interesting connections...
2/5
All part of the B3 clade, 1 seq attaches to autumn 2021 circulation in Europe/USA (1), 1 attaches back to European circulation in autumn 2019 (2), and the rest attach back to USA+ circulation in autumn 2019 (3).
Recently I've heard from collaborators in the US & Europe that #Enterovirus#D68#EVD68 cases are on the rise.
EV-D68 is what I worked on pre-pandemic, & hope to go back to.
A significant autumn 2022 wave has been a recent concern.
So what is D68 & what might this mean?
1/17
#EVD68 is a Picornavirus - a diverse family of viruses. And Enteroviruses are pretty diverse themselves: from Poliovirus, which can cause serious neurological illness, to Rhinovirus - what's behind the common cold 🤧 (and even more in between).
2/17
One of the most notable things about #EVD68 is that in Europe & North America it's historically had biennial autumn outbreaks: in 2014, 2016, & 2018. Also predicted in 2020... but that didn't happen due to pandemic!
Following that pattern, 2022 would be an outbreak season🗓️
"Are we better prepared?" asks @EckerleIsabella as she closes #SSM@SwissMicrobe with her keynote on challenges in prevention & preparedness for emerging viruses. #SARSCoV2 & #monkeypox have highlighted these issues; what do we know & where do we stand?
1/N
Perhaps particularly of note are viruses that aren't entirely new, but keep popping up, or appear in new hosts, new places, or with new symptoms a while after identification. How & how often does this happen?
Others we know well & have fought before, but appear again!
2/N
Understanding viral emergence is also not just for viral biologists: there are so many factors that provide influence, from that virus and host to environmental, anthropic, and human-animal interface.
Why is #opendata useful? It's much easier for scientists to share, create tools for, & publicly analyze open sequences.
For example, @Nextstrain creates the #monkeypox builds with open data & provides curated seqs+meta